Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Jazz Pharmaceuticals plc Director's Dealing 2024

Mar 6, 2024

30751_dirs_2024-03-05_23c7ec6d-6dcd-4389-8685-28c299c5f738.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2024-03-01

Reporting Person: Johnson Philip L (EVP & Chief Financial Officer)

More from Jazz Pharmaceuticals plc

Regulatory Filings 2026
May 29
Annual Report 2026
Apr 24
Major Shareholding Notification 2026
Mar 27
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
View all filings →